Cluster V&A Director
Pubblicato il 16-09-2026 - Kyowa Kirin International in Italia
Overview
Cluster V&A; Director
at Kyowa Kirin International plc
Milan - Italy
WE PUSH THE BOUNDARIES OF MEDICINE.
LEAPING FORWARD TO MAKE PEOPLE SMILE
At Kyowa Kirin International (KKI), our purpose is to make people smile. This means more than drug discovery and development; it is about embedding care into everything we do to make a difference every day for those that need it most. We’re an inclusive pharmaceutical company that takes time to understand what really matters to our patients, their families, and their healthcare professionals, helping our people to take bold actions that deliver life‑changing solutions sooner. Our culture is rooted in our values: Teamwork, Commitment to Life, Innovation, and Integrity. They help us to push boundaries to deliver extraordinary impact and make KKI a brilliant place to work.
Job Purpose
As Cluster Value & Access Director – Southern Cluster, you will be at the forefront of improving patient access to Kyowa Kirin’s innovative medicines. In this highly visible leadership role, you will develop and execute market access, pricing,
and payer engagement strategies that support both current and future products.
Partnering with local, regional, and global teams, you will translate insights into impactful value propositions, lead HTA and reimbursement activities, and shape access strategies that deliver sustainable value for patients, healthcare systems, and Kyowa Kirin. This is an exciting opportunity to influence key access decisions and drive commercial success across the Southern Cluster.
Responsibilities
Key Responsibilities:
- Shape and deliver pricing, reimbursement, and market access strategies across the Southern Cluster (Italy, Spain, Portugal), driving optimal patient access and commercial success.
- Develop compelling value propositions, HTA submissions, value dossiers, and HEOR materials to support reimbursement and pricing objectives.
- Partner with affiliate, regional, and global teams to anticipate market access chall